These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1192571)

  • 1. Hypotensive effect of clonidine during sodium depletion in the rat.
    Pals DT
    Circ Res; 1975 Dec; 37(6):795-801. PubMed ID: 1192571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism.
    Keeton TK; Pettinger WA; Campbell WB
    Circ Res; 1976 Jun; 38(6):531-9. PubMed ID: 1269103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a renal alpha-adrenergic receptor inhibiting renin release.
    Pettinger WA; Keeton TK; Campbell WB; Harper DC
    Circ Res; 1976 May; 38(5):338-46. PubMed ID: 5201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine Restores Pressor Responsiveness to Phenylephrine and Angiotensin II in Ovine Sepsis.
    Lankadeva YR; Booth LC; Kosaka J; Evans RG; Quintin L; Bellomo R; May CN
    Crit Care Med; 2015 Jul; 43(7):e221-9. PubMed ID: 25860204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Pharmacol; 1977 Aug; 12(1):1-5. PubMed ID: 902672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
    Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
    Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive effect of [Sar1,Thr8]angiotensin II in spontaneously hypertensive sodium-depleted rats.
    Muñoz-Ramírez H; Khosla MC; Bumpus FM; Khairallah PA
    Am J Physiol; 1978 Apr; 234(4):H447-53. PubMed ID: 645884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of captopril induced hypotension in rats.
    Clarke DE; Wagner LB; Wagner LA
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):13-30. PubMed ID: 7020011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of frusemide, saralasin and hypotension on fetal plasma renin activity and on fetal renal function.
    Lumbers ER; Stevens AD
    J Physiol; 1987 Dec; 393():479-90. PubMed ID: 3328781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril-induced hypotension is inhibited by the bradykinin blocker HOE-140 in Na(+)-depleted marmosets.
    Panzenbeck MJ; Loughnan CL; Madwed JB; Winquist RJ; Fogal SE
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1221-8. PubMed ID: 7485552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reduction induced by chronic intracerebroventricular or peroral clonidine administration in rats with salt-dependent or angiotensin II-dependent hypertension.
    Zicha J; Řezáčová L; Behuliak M; Vaněčková I
    Physiol Res; 2022 Dec; 71(6):763-770. PubMed ID: 36426892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
    Armah BI; Hofferber E; Stenzel W
    Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II, plasma renin and sodium depletion as determinants of blood pressure response to saralasin in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    Circulation; 1980 May; 61(5):920-4. PubMed ID: 6988103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.